FDA.reportPublic FDA data

Femring 0.05 MG per 24HR 3 Month Vaginal System

RxCUI
848333
RxNorm name
Femring 0.05 MG per 24HR 3 Month Vaginal System
Display name
Femring 0.05 MG per 24HR 3 Month Vaginal System
Full name
Femring 0.05 MG per 24HR 3 Month Vaginal System
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:05

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
7aaa97f9-a9d1-c815-e053-2991aa0afb9eFemring 0.05 MG per 24HR 3 Month Vaginal System [PSN] · 90 DAY estradiol 0.00208 MG/HR Vaginal System [Femring] [SBD] · 90 DAY Femring 0.00208 MG/HR Vaginal System [SY] · Femring 0.05 MG per 24HR 3 Month Vaginal System [SY]47These highlights do not include all the information needed to use FEMRING safely and effectively. See Full Prescribing Information for FEMRING. Femring ® (estradiol acetate vaginal ring) Initial U.S. Approval: 197520251209